BP79

Overview

BP79 is a potent TSLP receptor inhibitor. BP79 disrupts TSLP -mediated ternary complex formation, blocks TSLPR - IL7Rα co-localization, binds and stabilizes TSLPR , and inhibits phosphorylated STAT3/6 . BP79 suppresses immune cell infiltration, secretion of IL-13 , IL-4 . BP79 can be used for the research of inflammation diseases, such as atopic dermatitis, allergic asthma, and allergic rhinitis.

Application

Products | Products > Disease Areas > Allergic Asthma | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Allergy | Products > Disease Areas > Skin Inflammation | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > JAK/STAT Signaling | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > STAT

Product Information

• Catalog No.: HY-206870
• CAS No.: 3104965-33-2
• Molecular Formula: C10H8Cl2N2O2
• Molecular Weight: 259.09
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source